<DOC>
	<DOCNO>NCT01036841</DOCNO>
	<brief_summary>Alarm-treatment well Desmopressin , synthetic analogue human vasopressin , consider evidence-based medicine ( EBM ) IA treatment monosymptomatic nocturnal enuresis ( MNE ) . Desmopressin exist three different formulation ambulant use : nasal spray , tablet lyophilisate ( MELT ) differences bioavailability ( spray 2 % , tablet 0.2 % , MELT 0.5 % ) . There 's insufficient evidence confirm actually use bioequivalent dos ( 10µg spray = 120µg MELT= 0.2mg tablet ) . Although frequently use , pharmacokinetic -dynamic data desmopressin available child . Due prolong half life , associate waterintoxication , nasal spray black box warn FDA longer recommend . For author oral formulation appear safer alternative . However , base clinical experience less response rate oral formulation , low biodisponibility suspect . Adult research confirm low bioavailability tablet also show major influence food-intake change gastro-intestinal motility . To achieve maximum efficacy , recommendation take desmopressin tablet 1 hour bedtime 2 hour meal : unrealistic schoolaged child since never 3 hour even meal bedtime . In 2005 dose response study demonstrate superior pharmaco-kinetic dynamic property desmopressin Lyophilisate MELT formula . Since result implicate superior action MELT , often change MELT recommend suboptimal response tablet : sublingual absorption would eliminate influence food-intake . However , statement 's evidence , since test conduct child fast condition . Only one clinical study demonstrate bioequivalence MELT tablet . Hypothesis desmopressin MELT formulation well bioavailability administer together meal due sublingual absorption .</brief_summary>
	<brief_title>Influence Food-intake Desmopressin Oral Tablets MELT-formulation</brief_title>
	<detailed_description />
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<mesh_term>Polyuria</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>child age 616 year old MNE nocturnal polyuria treat desmopressin tablet , non partial responder , change MELT formulation indicate accord international standard guideline . history urologic disease , diurnal urinary incontinence , diabetes insipidus , urinary tract infection , clinically significant disease No systemic use antibiotic , diuretic , medication influence urinary concentrate mechanism abnormality oral mucosa could influence drugrelease absorption</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>MNE nocturnal polyuria</keyword>
	<keyword>monosymptomatic nocturnal enuresis nocturnal polyuria</keyword>
</DOC>